Astrana Health (NASDAQ:ASTH) Coverage Initiated by Analysts at Barclays

Equities research analysts at Barclays began coverage on shares of Astrana Health (NASDAQ:ASTH - Get Free Report) in a research report issued on Tuesday, MarketBeat Ratings reports. The firm set an "equal weight" rating and a $36.00 price target on the stock. Barclays's target price points to a potential upside of 19.72% from the company's current price.

ASTH has been the subject of several other reports. Bank of America dropped their target price on Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a report on Tuesday, March 4th. Truist Financial reduced their price target on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research report on Tuesday, March 18th. Stifel Nicolaus lowered their target price on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research note on Thursday, February 20th. Robert W. Baird reduced their price target on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. Finally, Macquarie raised shares of Astrana Health to a "hold" rating in a research report on Monday, December 16th. Three analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Astrana Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $53.29.

Astrana Health Stock Performance

ASTH traded down $0.27 on Tuesday, reaching $30.07. The stock had a trading volume of 288,946 shares, compared to its average volume of 265,168. The company has a market cap of $1.51 billion, a P/E ratio of 23.13, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. Astrana Health has a 12-month low of $23.12 and a 12-month high of $63.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The business's 50-day moving average price is $33.17 and its two-hundred day moving average price is $41.24.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $665.21 million for the quarter, compared to analyst estimates of $617.24 million. Sell-side analysts forecast that Astrana Health will post 1.15 earnings per share for the current year.

Institutional Investors Weigh In On Astrana Health

Several large investors have recently added to or reduced their stakes in the business. Handelsbanken Fonder AB grew its stake in shares of Astrana Health by 4.7% in the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock worth $281,000 after acquiring an additional 400 shares in the last quarter. Quarry LP grew its stake in Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock worth $57,000 after purchasing an additional 471 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Astrana Health by 3.9% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,505 shares of the company's stock worth $773,000 after purchasing an additional 915 shares during the period. Swiss National Bank increased its holdings in Astrana Health by 1.1% during the 4th quarter. Swiss National Bank now owns 88,444 shares of the company's stock worth $2,789,000 after purchasing an additional 1,000 shares during the period. Finally, MetLife Investment Management LLC raised its position in Astrana Health by 4.7% in the 4th quarter. MetLife Investment Management LLC now owns 26,284 shares of the company's stock valued at $829,000 after purchasing an additional 1,173 shares in the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.